BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29565714)

  • 1. Preparation and Evaluation of a Modified Mohs Paste Mixed with Zinc Oxide 10% Topical Oil-Based Ointment.
    Tsuruta M; Miyoshi T; Tsuruyama M; Matsumoto S; Yamashina T; Irie K; Matsuo N; Itonaga T; Hiraki Y; Kawamata Y
    J Palliat Med; 2018 May; 21(5):598-603. PubMed ID: 29565714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Tumor Tissue Fixation Effects of Formulation Modified Mohs Pastes in Mice and Their Water-Absorbing Properties.
    Taguchi M; Shigeyama M; Ogawa N; Murata M; Hanioka N; Yamamoto H; Teramachi H
    Biol Pharm Bull; 2018 Dec; 41(12):1824-1829. PubMed ID: 30282851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and Evaluation of Modified Mohs Paste without Starch].
    Taguchi M; Shigeyama M; Ito N; Ogawa N; Takahashi C; Murata M; Hanioka N; Yamamoto H; Teramachi H
    Yakugaku Zasshi; 2017; 137(4):477-484. PubMed ID: 28381726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mixing procedure itself on the structure, viscosity, and spreadability of white petrolatum and salicylic acid ointment and the skin permeation of salicylic acid.
    Kitagawa S; Fujiwara M; Okinaka Y; Yutani R; Teraoka R
    Chem Pharm Bull (Tokyo); 2015; 63(1):43-8. PubMed ID: 25400272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental rationale for treatment of high-risk human melanoma with zinc chloride fixative paste. Increased resistance to tumor challenge in murine melanoma model.
    Kalish RS; Wood JA; Siegel DM; Kaye VN; Brooks NA
    Dermatol Surg; 1998 Sep; 24(9):1021-5. PubMed ID: 9754091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combination of Cryopreservation and Kneading Maintains the Usability of Mohs Paste.
    Okamoto H; Yoshikawa T; Takeuchi K; Deguchi S; Hatakenaka Y; Matsuoka H; Kawabata A; Nagai N
    Chem Pharm Bull (Tokyo); 2020; 68(6):516-519. PubMed ID: 32475854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The palliative efficacy of modified Mohs paste for controlling canine and feline malignant skin wounds.
    Fukuyama Y; Kawarai S; Tezuka T; Kawabata A; Maruo T
    Vet Q; 2016 Sep; 36(3):176-82. PubMed ID: 26828294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc-containing Mohs' paste affects blood flow and angiogenesis suppression.
    Nagashima D; Furukawa M; Yamano Y; Yamauchi T; Okubo S; Toho M; Ito Y; Izumo N
    Daru; 2021 Dec; 29(2):321-328. PubMed ID: 34417987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of plasma on the physical properties of ointments with quercetin.
    Szulc-Musioł B; Dolińska B; Kołodziejska J; Ryszka F
    Acta Pharm; 2017 Dec; 67(4):569-578. PubMed ID: 29337672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mohs' ointment use in controlling advanced head and neck cancer].
    Minami K; Hasegawa N; Fukuoka O; Miyajima C; Tsunoda R; Fukaya T
    Nihon Jibiinkoka Gakkai Kaiho; 2009 Jul; 112(7):550-3. PubMed ID: 19670797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies on zinc oxide ointment replacing boric acid and zinc oxide ointment (JP8)].
    Kubota K; Kumakiri M; Miura Y; Hine K; Kori N; Saito H; Miyazaki K; Arita T
    Hokkaido Igaku Zasshi; 1983 Jul; 58(4):400-5. PubMed ID: 6629312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frederic E. Mohs, MD, and the history of zinc chloride.
    DePaolo C
    Clin Dermatol; 2018; 36(4):568-575. PubMed ID: 30047439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc oxide paste as sunscreen in the postoperative period.
    Shimizu I; MacFarlane D
    Dermatol Surg; 2012 Jun; 38(6):965-6. PubMed ID: 22642456
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of clinical and radiological success of zinc oxide-ozonated oil, modified 3mix-mp antibiotic paste, and vitapex as treatment options in primary molars requiring pulpectomy: An
    Doneria D; Thakur S; Singhal P; Chauhan D
    J Indian Soc Pedod Prev Dent; 2017; 35(4):346-352. PubMed ID: 28914248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Concentration on Release and Permeation Process of Model Peptide Substance-Corticotropin-From Semisolid Formulations.
    Siemiradzka W; Dolińska B; Ryszka F
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of tretinoin tocoferil emulsion and povidone-iodine sugar ointment blend developed for improved regulation of wound moisture.
    Noda Y; Saito M; Watanabe K; Sanagawa A; Sobajima Y; Fujii S
    Chem Pharm Bull (Tokyo); 2013; 61(7):700-5. PubMed ID: 23676566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of formalin-fixed vs. frozen section Mohs surgery tissue preparation.
    Lawrence CM; Coaker T; Watson S; Langtry J
    Br J Dermatol; 2009 Aug; 161(2):488-9. PubMed ID: 19519835
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of an Ointment Formulation Using Hot-Melt Extrusion Technology.
    Bhagurkar AM; Angamuthu M; Patil H; Tiwari RV; Maurya A; Hashemnejad SM; Kundu S; Murthy SN; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):158-66. PubMed ID: 26628438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of Mohs' chemosurgery for palliative purposes in patients with cutaneous squamous cell carcinoma with risk factors or without indication for surgery: three case reports.
    Nakai N; Okuzawa Y; Katoh N
    J Dermatol; 2015 Apr; 42(4):405-7. PubMed ID: 25583451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.